Lv1
60 积分 2025-04-22 加入
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
1个月前
已完结
AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models
1个月前
已完结
Omics profiling of CDK4/6 inhibitors reveals functionally important secondary targets of abemaciclib (Conference Presentation)
1个月前
已关闭
The rise of AlphaFold in drug design
4个月前
已完结
Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2
4个月前
已完结
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancer
5个月前
已完结
Recent advances in interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors and PROTACs
8个月前
已完结
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
8个月前
已完结
BTK-independent regulation of calcium signalling downstream of the B-cell receptor in malignant B-cells
8个月前
已完结
A Computational Model for Early Events in B Cell Antigen Receptor Signaling: Analysis of the Roles of Lyn and Fyn
9个月前
已完结
皖公网安备34019202002308
